Intratumoral G100 Induces Systemic Immunity and Abscopal Tumor Regression in Patients with Follicular Lymphoma: Results of a Phase 1/2 Study Examining G100 Alone and in Combination with Pembrolizumab. 59th American Society of Hematology (ASH) Annual meeting. Abstract # 2771. View Poster.

Click here to follow the story.

Publications